⌘K

Login Start Free

Home/Filings/4/0000950170-24-025839

4//SEC Filing

Scott Randal W. 4

Accession 0000950170-24-025839

CIK 0001743881other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:00 PM ET

Size

5.4 KB

Accession

0000950170-24-025839

Insider Transaction Report

Form 4

Period: 2024-03-01

BridgeBio Pharma, Inc.BBIO

Director

Transactions

Sale
Common Stock
2024-03-01$34.00/sh−2,500$85,000→ 6,500 total(indirect: By LLC)

Holdings

Common Stock
5,000

Footnotes (1)

[F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1

filerCIK 0001337801

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 4:00 PM ET
Size: 5.4 KB

View on SEC.gov